SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Helius Medical Technologies, Inc. – ‘10-K’ for 12/31/22 – ‘ZIP’

On:  Thursday, 3/9/23, at 4:39pm ET   ·   For:  12/31/22   ·   Accession #:  1558370-23-3338   ·   File #:  1-38445

Previous ‘10-K’:  ‘10-K’ on 3/14/22 for 12/31/21   ·   Next & Latest:  ‘10-K’ on 3/28/24 for 12/31/23   ·   30 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/09/23  Helius Medical Technologies, Inc. 10-K       12/31/22   76:7.8M                                   Toppan Merrill Bridge/FA

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.15M 
 2: EX-21.1     Subsidiaries List                                   HTML     22K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML     21K 
 4: EX-23.2     Consent of Expert or Counsel                        HTML     21K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
13: R1          Document and Entity Information                     HTML     92K 
14: R2          Consolidated Balance Sheets                         HTML    123K 
15: R3          Consolidated Balance Sheets (Parenthetical)         HTML     38K 
16: R4          Consolidated Statements of Operations and           HTML    133K 
                Comprehensive Loss                                               
17: R5          Consolidated Statements of Stockholders' Equity     HTML     91K 
18: R6          Consolidated Statements of Cash Flows               HTML    123K 
19: R7          Description of Business                             HTML     27K 
20: R8          Significant Accounting Policies                     HTML     40K 
21: R9          Goodwill Impairment                                 HTML     24K 
22: R10         Supplemental Balance Sheet Disclosures              HTML     83K 
23: R11         Leases                                              HTML     35K 
24: R12         Intangible Assets                                   HTML     70K 
25: R13         Fair Value Measurements                             HTML     27K 
26: R14         Common Stock and Warrants                           HTML     64K 
27: R15         Stock-Based Compensation                            HTML    102K 
28: R16         Basic and Diluted Loss Per Share                    HTML     55K 
29: R17         Income Taxes                                        HTML    122K 
30: R18         Defined Contribution Plan                           HTML     24K 
31: R19         Commitments and Contingencies                       HTML     24K 
32: R20         Enterprise-Wide Disclosures                         HTML     42K 
33: R21         Significant Accounting Policies (Policies)          HTML     96K 
34: R22         Supplemental Balance Sheet Disclosures (Tables)     HTML     85K 
35: R23         Leases (Tables)                                     HTML     34K 
36: R24         Intangible Assets (Tables)                          HTML     72K 
37: R25         Common Stock and Warrants (Tables)                  HTML     53K 
38: R26         Stock-Based Compensation (Tables)                   HTML    101K 
39: R27         Basic and Diluted Loss Per Share (Tables)           HTML     56K 
40: R28         Income Taxes (Tables)                               HTML    125K 
41: R29         Enterprise-Wide Disclosures (Tables)                HTML     37K 
42: R30         Description of Business (Details)                   HTML     36K 
43: R31         SIGNIFICANT ACCOUNTING POLICIES - Additional        HTML     34K 
                Information (Details)                                            
44: R32         Goodwill Impairment (Details)                       HTML     26K 
45: R33         SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Accounts   HTML     30K 
                receivable, net (Details)                                        
46: R34         SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Inventory  HTML     35K 
                (Details)                                                        
47: R35         SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Prepaid    HTML     27K 
                expenses and other current assets (Details)                      
48: R36         SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Property   HTML     35K 
                and equipment, net (Details)                                     
49: R37         SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Accrued    HTML     36K 
                Expenses (Details)                                               
50: R38         SUPPLEMENTAL BALANCE SHEET DISCLOSURES - Deferred   HTML     47K 
                Revenue (Details)                                                
51: R39         Leases (Details)                                    HTML     48K 
52: R40         INTANGIBLE ASSETS - Summary (Details)               HTML     39K 
53: R41         INTANGIBLE ASSETS - Estimated Amortization Expense  HTML     28K 
                (Details)                                                        
54: R42         COMMON STOCK AND WARRANTS - Additional Information  HTML    107K 
                (Details)                                                        
55: R43         COMMON STOCK AND WARRANTS - Summary of Weighted     HTML     70K 
                Average Assumptions Used in Estimating Fair Value                
                of Warrants (Details)                                            
56: R44         COMMON STOCK AND WARRANTS - Summary of Warrant      HTML     39K 
                Activity (Details)                                               
57: R45         STOCK-BASED COMPENSATION - Additional Information-  HTML     67K 
                (Details)                                                        
58: R46         STOCK-BASED COMPENSATION - Fair Value Assumptions   HTML     33K 
                (Details)                                                        
59: R47         STOCK-BASED COMPENSATION - Summary of Company's     HTML     48K 
                Stock Option Activity (Details)                                  
60: R48         STOCK-BASED COMPENSATION - Other Awards (Details)   HTML     38K 
61: R49         STOCK-BASED COMPENSATION - Stock-Based              HTML     30K 
                Compensation Expense (Details)                                   
62: R50         Basic and Diluted Loss Per Share (Details)          HTML     50K 
63: R51         Basic and Diluted Loss Per Share - Antidilutive     HTML     30K 
                Securities (Details)                                             
64: R52         INCOME TAXES - Components of Net Loss for Income    HTML     31K 
                Tax (Details)                                                    
65: R53         INCOME TAXES - Reconciliation of Income Tax         HTML     47K 
                Provision Computed at Statutory Rates (Details)                  
66: R54         INCOME TAXES - Components of Deferred Income Tax    HTML     60K 
                Assets and Liabilities (Details)                                 
67: R55         INCOME TAXES - Net operating losses (Details)       HTML     46K 
68: R56         INCOME TAXES - Tax credit carryforward (Details)    HTML     37K 
69: R57         Defined Contribution Plan (Details)                 HTML     30K 
70: R58         COMMITMENTS AND CONTINGENCIES - Additional          HTML     27K 
                Information (Details)                                            
71: R59         Enterprise-Wide Disclosures (Details)               HTML     52K 
74: XML         IDEA XML File -- Filing Summary                      XML    135K 
72: XML         XBRL Instance -- hsdt-20221231x10k_htm               XML   1.59M 
73: EXCEL       IDEA Workbook of Financial Reports                  XLSX     92K 
 9: EX-101.CAL  XBRL Calculations -- hsdt-20221231_cal               XML    190K 
10: EX-101.DEF  XBRL Definitions -- hsdt-20221231_def                XML    474K 
11: EX-101.LAB  XBRL Labels -- hsdt-20221231_lab                     XML   1.36M 
12: EX-101.PRE  XBRL Presentations -- hsdt-20221231_pre              XML    930K 
 8: EX-101.SCH  XBRL Schema -- hsdt-20221231                         XSD    160K 
75: JSON        XBRL Instance as JSON Data -- MetaLinks              423±   633K 
76: ZIP         XBRL Zipped Folder -- 0001558370-23-003338-xbrl      Zip    326K 


‘ZIP’   —   XBRL Zipped Folder — 0001558370-23-003338-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:hsdt-20221231.xsd
hsdt-20221231_cal.xml
hsdt-20221231_def.xml
hsdt-20221231_lab.xml
hsdt-20221231_pre.xml
hsdt-20221231x10k.htm
hsdt-20221231x10k001.jpg
hsdt-20221231x10k002.jpg
hsdt-20221231x10k003.jpg
hsdt-20221231x10k004.jpg
hsdt-20221231xex21d1.htm
hsdt-20221231xex23d1.htm
hsdt-20221231xex23d2.htm
hsdt-20221231xex31d1.htm
hsdt-20221231xex31d2.htm
hsdt-20221231xex32d1.htm


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/23/23  Helius Medical Technologies, Inc. 424B5                  1:387K                                   Toppan Merrill/FA
 5/25/23  Helius Medical Technologies, Inc. S-3/A                  3:378K                                   Toppan Merrill/FA
 3/10/23  Helius Medical Technologies, Inc. S-3                    9:1.1M                                   Toppan Merrill/FA


27 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/30/22  Helius Medical Technologies, Inc. 8-K:4,9     9/26/22   11:182K                                   Toppan Merrill Bridge/FA
 8/09/22  Helius Medical Technologies, Inc. 8-K:1,3,8,9 8/05/22   16:1M                                     Toppan Merrill/FA
 2/18/22  Helius Medical Technologies, Inc. 8-K:5,9     2/16/22   12:618K                                   ActiveDisclosure/FA
 9/03/21  Helius Medical Technologies, Inc. S-1                    5:483K                                   Donnelley … Solutions/FA
 9/02/21  Helius Medical Technologies, Inc. 8-K:1,3,9   9/01/21   12:556K                                   Donnelley … Solutions/FA
 7/07/21  Helius Medical Technologies, Inc. S-8         7/07/21    5:268K                                   Donnelley … Solutions/FA
 6/15/21  Helius Medical Technologies, Inc. 8-K:5,7,9   6/14/21    5:638K                                   ActiveDisclosure/FA
 5/27/21  Helius Medical Technologies, Inc. 8-K:5,9     5/25/21    2:97K                                    ActiveDisclosure/FA
 5/17/21  Helius Medical Technologies, Inc. 10-Q        3/31/21   57:7.5M                                   ActiveDisclosure/FA
 4/07/21  Helius Medical Technologies, Inc. 8-K:5,9     4/01/21    3:159K                                   ActiveDisclosure/FA
 3/10/21  Helius Medical Technologies, Inc. 10-K       12/31/20   75:11M                                    ActiveDisclosure/FA
 2/01/21  Helius Medical Technologies, Inc. 8-K:1,3,8,9 1/28/21    5:522K                                   ActiveDisclosure/FA
 1/20/21  Helius Medical Technologies, Inc. S-1/A                 81:14M                                    Donnelley … Solutions/FA
12/31/20  Helius Medical Technologies, Inc. 8-K:3,5,8,912/31/20    3:73K                                    ActiveDisclosure/FA
10/26/20  Helius Medical Technologies, Inc. 8-K:1,3,8,910/21/20    4:504K                                   ActiveDisclosure/FA
10/07/20  Helius Medical Technologies, Inc. 8-K:5,9    10/05/20    2:193K                                   ActiveDisclosure/FA
 3/14/19  Helius Medical Technologies, Inc. 10-K       12/31/18   74:13M                                    ActiveDisclosure/FA
11/08/18  Helius Medical Technologies, Inc. 10-Q        9/30/18   64:11M                                    ActiveDisclosure/FA
10/30/18  Helius Medical Technologies, Inc. 8-K:5,9    10/24/18    2:50K                                    Donnelley … Solutions/FA
 8/09/18  Helius Medical Technologies, Inc. 10-Q        6/30/18   65:11M                                    ActiveDisclosure/FA
11/09/17  Helius Medical Technologies, Inc. 10-Q        9/30/17   57:7.5M                                   ActiveDisclosure/FA
11/02/17  Helius Medical Technologies, Inc. 8-K:1,9    10/30/17    2:63K                                    ActiveDisclosure/FA
 5/18/17  Helius Medical Technologies, Inc. S-8         5/18/17    9:1.2M                                   Donnelley … Solutions/FA
 4/03/17  Helius Medical Technologies, Inc. 10-KT      12/31/16   71:10M                                    ActiveDisclosure/FA
10/16/15  Helius Medical Technologies, Inc. 8-K:1,2,3,810/09/15    4:199K                                   Newsfile Corp./FA
 9/23/14  Helius Medical Technologies, Inc. S-1/A                 11:1.3M                                   Newsfile Corp./FA
 7/14/14  Helius Medical Technologies, Inc. S-1         7/11/14   16:7.9M                                   Michener Lang
Top
Filing Submission 0001558370-23-003338   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 6:44:18.3pm ET